Medical research

Researchers unravel omicron's secrets to better understand COVID-19

When South African scientists announced in November that they had identified a new variant of the virus that causes COVID-19, they also reported two worrying details: one, that this new variant's genome was strikingly different ...

Diseases, Conditions, Syndromes

New osteoporosis therapy's dual effects on bone tissue

Sclerostin is a protein produced by osteocytes in the bone that inhibits bone formation. A recent analysis of results from a clinical trial reveals the beneficial effects of romosozumab, an antibody therapy that targets sclerostin, ...

Medications

New monoclonal antibody shows promise for severe asthma

A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health ...

Diseases, Conditions, Syndromes

New study shows common antibody therapy has anti-SARS-CoV-2 antibodies

Researchers at the University of Texas Medical Branch recently confirmed the presence of neutralizing antibodies to SARS-CoV-2 in a common subcutaneous antibody therapy (Hizentra) used to treat immunocompromised or immunodeficient ...

Diseases, Conditions, Syndromes

New potential approach to treat atopic dermatitis

How does the immune system respond to fungi on our skin? Researchers at the University of Zurich have demonstrated that the same immune cells that protect us against skin fungi also encourage the inflammatory symptoms of ...

Other

After 55 years, surgery restores sight

After being hit in the eye by a stone, a detached retina left a man blind in his right eye. Despite surgery to remove a cataract when the man was 23, which temporarily restored light perception, the patient was completely ...

page 4 from 16